TrialJournal of Crohn's & colitis2019

Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials.

Stephen Hanauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.